CS Diagnostics Corp. (CSDX)

OTCMKTS · Delayed Price · Currency is USD
0.0700
+0.0216 (44.63%)
Jun 26, 2025, 4:00 PM EDT
-86.54%
Market Cap 9.61M
Revenue (ttm) n/a
Net Income (ttm) -341.61K
Shares Out 137.34M
EPS (ttm) -3.54
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 142,379
Average Volume 81,408
Open 0.0400
Previous Close 0.0484
Day's Range 0.0400 - 0.0700
52-Week Range 0.0360 - 5.6400
Beta -21.57
RSI 46.45
Earnings Date n/a

About CS Diagnostics

CS Diagnostics Corp. manufactures and sells medical products for medicine, radiology, cardiology, and radiation therapy in Germany and internationally. The company offers injectors, pistons, hose systems, PCR tests, medicines, and gloves. It also operates as a pharmaceutical wholesaler. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Neuss, Germany. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1996
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol CSDX
Full Company Profile

Financial Performance

Financial Statements

News

CS Diagnostics Corp. to Present at the Small Cap Growth Virtual Investor Conference June 26th

DUBAI, United Arab Emirates, June 24, 2025 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX), based in Germany and USA and focused on innovation in Healthcare, today announced that Thomas Fahrhoe...

3 days ago - GlobeNewsWire

CS Diagnostics Corp. CSDX to Present at the Small Cap Growth Virtual Investor Conference on June 26, 2025 at 12:30pm EDT

NEUSS, DE / ACCESS Newswire / June 18, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) a global leader in innovative healthcare solutions announced its participation in the Small Cap Growth Virtual Investor ...

9 days ago - Accesswire

CS Diagnostics Corp. is Entering into a $5 Million Loan Agreement with SAN ART CAPITAL SAS

CHEYENNE, WY / ACCESS Newswire / April 15, 2025 / Neuss, Germany: CS Diagnostics Corp. is pleased to announce that it has received a Letter of Intent from SAN ART CAPITAL SAS, a leading advisory and i...

2 months ago - Accesswire

OTCQB-CSDX Appoints Lachman Consultants for CS-Protect Hydrogel FDA Approval

CS DIAGNOSTICS CORP. ANNOUNCES THE APPOINTMENT OF FDA CONSULTANTS Innovative tissue spacer technology for cancer radiology treatments CHEYENNE, WY / ACCESS Newswire / March 12, 2025 / CS Diagnostics C...

3 months ago - Accesswire

CS Diagnostics Corp. Announces U.S. Launch of MEDUSA

NEUSS, Germany--(BUSINESS WIRE)--CS Diagnostics Corp. Announces U.S. Launch of MEDUSA.

5 months ago - Business Wire